Creative
answers to your
challenges

The Tokyo office in Japan has just been established.

More

Creativ-Ceutical in force to attend ISPOR 17th Annual European Congress, on 8-12 November 2014 in Amsterdam with many contributions.

More

Successful ISPOR meeting in Beijing! One of our podium presentations awarded!

More

Scrip Intelligence has referred to Creativ-Ceutical's report in the article "External reference pricing goes global": [...] Similar reservations about ERP are expressed in a more recent report on its use in the EU, produced for the European Commission by the consultancy Creativ-Ceutical. This found that ERP is used by all 28 EU countries apart from [...]

More

ISPOR endorses Creativ-Ceutical's team on academic research for their article published in Value in Health.

More

Submit an article to the JMAHP, the new open access journal of market access and health policy supported by Creativ-Ceutical.

More

The EU Commission requested Creativ-Ceutical to provide a forecast model to assess the impact of new patented medicinal products versus medicinal products going off-patent until 2016, and in 7 EU countries.

More

Have a look at our recent publications.

More

“ The innovative model developed  for pharmaceutical expenditure forecast allowed to inform the European Commission on how Member States' public pharmaceutical expenditures are likely to evolve over the next few years, both from medicinal products going off patent and from new patent medicinal products.”EU Commission DG SANCO

“Creativ-Ceutical has helped Air Liquide Santé International to assess new indications for long-known molecule. Hard-workers and based on strict methodology, they have been great consultants and proven highest added value to internal thinking. ”International Medical Director, Air Liquide Santé International World Business Line